Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1999
10/21/1999WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999WO1999047102A3 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999WO1999040061A3 Novel dihydroxyhexanoic acid derivatives
10/21/1999WO1999036553A3 Regulation of biological events using multimeric chimeric proteins
10/21/1999WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
10/21/1999DE19817461A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999CA2327431A1 Pharmaceutical composition
10/21/1999CA2326618A1 Inhibition of xenoreactive antibodies
10/21/1999CA2325939A1 Vaccine
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325629A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999CA2323733A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950412A2 Compositions for treating allergic disorders using (-) cetirizine
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950101A1 Secreted proteins and polynucleotides encoding them
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999EP0832078B1 N-hydroxyureas as antiinflammatory agents
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999EP0673250B1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
10/20/1999CN1232503A Tumor necrosis factor related ligand
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs.
10/20/1999CN1232448A Vitamin D analogues
10/20/1999CN1232447A Hydroxamic acid derivs.
10/20/1999CN1232443A Novel p-terphenyl compounds
10/20/1999CN1232398A IL-8 receptor antagonists
10/20/1999CN1231918A Human immunization strengthening medicine
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/20/1999CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same
10/19/1999US5969184 Amide compounds
10/19/1999US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999US5969125 Polynucleotideds that encode polypeptides that can be used to generate antibodies to prevent, treat, and reduce effects of disease
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5969093 Secreted proteins
10/19/1999US5968949 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals
10/19/1999US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999US5968910 Two or three compounds which do not select for same mutantstrains; preventtion or treatment of htlv infections
10/19/1999US5968898 THF-γ2 analogs and pharmaceutical compositions comprising them
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968815 Promoter of M. paratuberculosis and its use for the expression of immunogenic sequences
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999US5968768 CD6 ligand encoding sequence
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968733 Mycobacteriophages and uses thereof
10/19/1999US5968526 Mixing blood sample with peptide isolated from dust mite allergen protein to determine amount of binding which will indicate degree of sensitivity
10/19/1999US5968519 Antiinflammatory agents or analgesics in mammals
10/19/1999US5968516 Soybean drug and new method of extracting soybean saponins
10/19/1999US5968515 Coupling thermally and hydrolytically labile compounds such as spectinomycin to immunogenic carriers; conjugation, crosslinking in presence of hydroxylimide catalyst; activating with carbodiimide
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968510 CTLA4 receptor and uses thereof
10/19/1999US5968509 Antibodies with binding affinity for the CD3 antigen
10/16/1999CA2269046A1 Method of preventing allograft rejection
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051580A1 Pyrazole inhibitors of cytokine production
10/14/1999WO1999051275A2 Mesenchymal stem cells as immunosuppressants
10/14/1999WO1999051273A1 Gelling ophthalmic compositions containing xanthan gum
10/14/1999WO1999051269A1 Adjuvant-containing vaccines
10/14/1999WO1999051267A1 Hiv-specific cytotoxic t-cell responses
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051259A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051257A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999WO1999051251A1 Use of extracts of bearberry leaves (arctostaphylos uva ursi), birch leaves (betula), horsetail (equisetum) and stinging nettle (urtica)
10/14/1999WO1999051250A1 Use of extracts of echinacea pallida and echinacea angustifolia, dandelion (taraxacum) and plantain (plantago)
10/14/1999WO1999051249A1 Herbal composition for the prophylaxis and treatment of aids
10/14/1999WO1999051234A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051215A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
10/14/1999WO1999051213A2 The use of polyamines in the treatment of dermatological symptoms
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
1 ... 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 ... 1172